Heart failure is a devastating disease of epidemic proportions. Physicians are faced with an increasingly large choice of treatment options and questions including: how different genetic, racial and gender backgrounds can influence a patient's response; how to monitor treatment once it has begun; and what side-effects can be expected from these agents.
Heart Failure: Pharmacologic Management is the essential guide for physicians working with these issues to optimise their use of pharmacologic therapy for patients with heart failure.

This extensively referenced text provides both the biologic and pathologic underpinning for the use of eachpharmacologic agent currently recommended, including the clinical investigations that have led to our understanding of the risks and benefits associated with the use of these drugs. In addition, this book reviews several areas, including vasopressin antagonists, that are under active investigation, but which are expected to prove fruitful in the therapy of patients with heart failure.

Heart Failure: Pharmacologic Management is written by individuals with extensive expertise within the field and is the only text to focus on pharmacologic therapy. It will assist the practitioner in easily making sense of the extensive number of treatment agents available and should be considered a vital contribution to your bookshelf.